PTEN and colorectal carcinoma: RES exhibits anti-proliferative and apoptosis-inducing activities on CRC cells by upregulating bone morphogenetic proteins (BMP7) and tensin homolog (PTEN) (75, 76), as well as enhanced sensitivity of CRC cells to cetuximab chemotherapy by upregulating connexin-43 (77).